Precision BioSciences Inc. (NASDAQ: DTIL)
$10.31
+0.0650 ( +0.64% ) 59.2K
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Market Data
Open
$10.31
Previous close
$10.24
Volume
59.2K
Market cap
$71.89M
Day range
$10.05 - $10.39
52 week range
$8.25 - $21.30
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 67 | May 13, 2024 |
8-k | 8K-related | 13 | May 13, 2024 |
4 | Insider transactions | 1 | May 08, 2024 |
4 | Insider transactions | 1 | May 08, 2024 |
8-k | 8K-related | 11 | May 08, 2024 |
4 | Insider transactions | 1 | May 08, 2024 |
4 | Insider transactions | 1 | May 08, 2024 |
4 | Insider transactions | 1 | May 07, 2024 |
4 | Insider transactions | 1 | May 07, 2024 |
4 | Insider transactions | 1 | May 07, 2024 |